David C Bloom

David C Bloom

PROFESSOR

Department: MD-MOLECULAR GENTCS / MICROBIO
Business Phone: (352) 273-9524
Business Email: dbloom@ufl.edu

Publications

2017 Methods in Molecular Biology
2014 Computational and Structural Biotechnology Journal
2010 Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms

Grants

August 2019ACTIVE
Phenotypic analyses of HSV-1 miRNAs: H1, H6, & H8
NATL INST OF HLTH NIAID · Mentor
March 2019ACTIVE
Molecular Genetics of HSV Reactivation
NATL INST OF HLTH NIAID · Principal Investigator
November 2018ACTIVE
CTCF-mediated HSV-1 gene expression during latency and reactivation
UNIV OF WISCONSIN MADISON · Principal Investigator
October 2018ACTIVE
Analysis of the specific effects of Tranexamic Acid on HSV infection
ANTI PLASMIN TECHNOLOGIES · Principal Investigator
September 2016 – August 2018
Analysis of human-specific aspects of HSV-1 latency in human iPSC-derived neurons
UNIV OF PITTSBURGH · Principal Investigator
June 2016 – May 2018
OR-DRPD-ROF2016: Visualizing viral entry into neurons and the brain: Changing the paradigm
UF DSR OPPORTUNITY FUND · Project Manager
January 2016 – December 2016
Vector-delivered CRISPR/Cas as a cure for HSV-1 induced
EDITAS MEDICINE · Principal Investigator
September 2015 – August 2016
The Role of the LAT Locus in HSV-1 Infection
STANFORD UNIV · Principal Investigator
July 2015 – June 2018
Function of histone chaperones in HSV-1 chromatin sturct
NATL INST OF HLTH NIAID · Project Manager
June 2015 – June 2016
Effect of spaceflight on Herpesvirus genome stability and diversity
NASA · Principal Investigator
August 2014ACTIVE
Basic Microbiology and Infectious Disease
NATL INST OF HLTH NIAID · Principal Investigator
August 2014 – April 2017
Cytotoxic lymphocytes and HSV-1 corneal lesions
UNIV OF PITTSBURGH · Principal Investigator
January 2014 – January 2017
Determination of Roles of Microgravity and Ionizing Radi
NASA STENNIS SPACE FLIGHT CTR · Principal Investigator
July 2013ACTIVE
Evaluation of the suitability of SafeSwitch-controlled HSV as anti-herpetic"vaccines" or as immunization platform
HSF PHARMACEUTICALS SA · Principal Investigator
January 2012 – December 2017
Regulation of lytic and latent infection by HSV-1 encode
NATL INST OF HLTH NIAID · Principal Investigator
July 2010ACTIVE
HSV-1 Research Program – UFF Transfer Account
UF FOU · Principal Investigator
July 2010ACTIVE
HSV-2 Research Program – UFF Transfer Account
UF FOU · Principal Investigator

Patents

Issued May 2017
Insulated Herpesvirus-derived Gene Expression Cassette for Sustained and Regulatable Gene Expression (DIV 11434)
9,636,354
Published September 2016
Method for the Treatment of Latent Infection with HSV-1 or HSV-2
US2017/0020994
Issued May 2015
Insulated Herpesvirus-derived Gene Expression Cassette for Sustained and Regulatable Gene Expression
9,023,617
Issued November 2010
Herpesvirus Ribozymes and Vectors (CIP)
7,838,659
Issued February 2008
Herpesvirus Ribozymes and Vectors
7,335,763
Issued May 1993
Biological System for Constructing and Testing Viral Vaccines Culture Of Poxvirus and Plasmids
5,212,057

Contact Details

Phones:
Business:
(352) 273-9524
Emails:
Business:
dbloom@ufl.edu
Addresses:
Mailing:
PO Box 100266
GAINESVILLE, FL 32610
Physical:
1200 NEWELL DR
GAINESVILLE, FL 32610